HIV Testing Is The Key To Controlling This Virus

HIV testing results are the key to fighting this virus

The National HIV Testing Day is on Jun 27, 2019, and the Health Resources Services Administration (HRSA) highlights the importance of being tested for HIV, identifying your HIV state, and finding the HIV treatment and care if you test positive.

This season’s central theme, “Doing It My Way,” provides knowledge on how taking an HIV test may be an empowering experience while also knowing that you can do it in your way. Whichever form you do it, this National HIV Testing Day, HRSA supports those in danger to get examined for HIV.

Around 1.1 million people in the U.S. have HIV, but one in seven individuals with HIV is unaware that they are infected, according to the Centers for Disease Control and Prevention.

HRSA’s Ryan White HIV/AIDS Program finances programs and providers that play a crucial role in finding, analyzing, and providing primary HIV medical care and treatment for low-income individuals with HIV that are uninsured and underserved.

Ending the HIV Epidemic: A Strategy for America

This Testing Day, we realize that at this moment, there is a possibility in America to prevent the HIV disease. Earlier this year, the Administration introduced the “Ending the HIV Epidemic: A Plan for America” initiative, a 10-year plan starting in FY 2020 to achieve the objective of reducing new HIV infections to less than 3,000 each year by 2030.

During the HRSA-funded Health Center Program and the HRSA’s Ryan White HIV/AIDS Program, the agency will play a significant role in helping prevent, diagnose, treat, and respond to finish the HIV pandemic.

Today HRSA declared the award of approximately one million dollars in Ryan White HIV/AIDS Project grants to 10 metropolitan regions to provide technical assistance activities to improve efforts to cease the HIV epidemic in Part A jurisdictions.

Supporting the Ryan White HIV/AIDS Program Part A, 52 metropolitan areas provide heart medical and support services to individuals with HIV. The funding granted now supporting the Building Capacity for HIV Elimination in Ryan White HIV/AIDS Program Part A Jurisdiction project provides technical aid to intensify efforts to stop the HIV epidemic through developments across the HIV care continuum.

The Significance of Treatment and Testing

People with HIV who take HIV medication as prescribed, and get and maintain an undetectable viral load, have no chance of sexually transmitted the infection to their HIV-negative spouse. This finding highlights the significance of getting people with HIV tested, associated with HIV treatment and care, and helping them remain in care and on their medication.

HRSA’s Ryan White HIV/AIDS Program funds grant to states, cities/counties,  and local community-based groups to present a comprehensive system of HIV primary medical care, prescription, and necessary support services to low-income individuals with HIV.

Over fifty percent of individuals with diagnosed HIV in the U.S. — over 500,000 people — get care through the Ryan White HIV/AIDS Program every year. In 2017, 85.9percent of Ryan White HIV/AIDS Program customers were finally suppressed, surpassing the viral suppression national average of 60%.

Find Care and Get Tested

So again, with HRSA, this National HIV Testing Day supports people in danger to get examined for HIV. If your result is positive, the Ryan White HIV/AIDS Program and the Health Center Program will help you to get the treatment and care you need and find a medical care provider.

Near-Universal Screening for HIV Advocated in the U.S.

You would be shocked to learn that the U.S. has more folks with new HIV diagnoses every year than high-income country. There is this general delusion out there that we have got it under control; the drug cocktails are so potent that HIV is no longer a top threat.

“Unfortunately, HIV remains a major public health problem in the U.S.,” stated Stanford Health Policy’s Douglas Owens, MD. He’s chair of the U.S. Preventive Services Task Force, which issued two compelling recommendations about the treatment and prevention of HIV in the Journal of the American Medical Association.

The task force now urges clinicians screen everyone aged 15 to 65 and all pregnant women for HIV and extends pre-exposure prophylaxis (PrEP) — a pill that will aid prevent HIV — to individuals at high chance of contracting the potentially deadly infection.

“There are highly effective preventive interventions that can help us toward the goal of ending the HIV epidemic in the U.S.,” said Owens, who’s also an analyst at VA Palo Alto Health Care System “However, we know not enough people receive these interventions.”

Owens said an expected 1.1 million people are presently living with HIV in this nation — and over 700,000 people have died of AIDS since the initial cases were listed in 1981. Of the 38,281 new tests of HIV reported in 2017, 81% were among men and 19% among women.

“Each year, almost 40,000 people acquire HIV,” he said. “It’s not acceptable and requires our urgent attention.”

The task force is a self-governing, missionary panel of national specialists in stopping and evidence-based medicine who work to better the health of all Americans by making recommendations. They generally provide letter grades to its own recommendations, and this time issued its highest degree, an A.

The advantage of this support could be substantial, According to one of the similar editorials in JAMA, because according to the Affordable Care Act, grade A and B support made by the USPSTF ought to be covered by personal insurance without patient cost-sharing.

“How this recommendation will be implemented is of critical importance because the cost is a major barrier for people both to start and to stay on PrEP,” stated Susan Buchbinder, MD, and Diane Havlir, MD, both from the University of California, San Francisco, in their report. At present, they formulated, the average monthly retail price for PrEP without insurance is around $2,000.

The task force group decided “with high assurance” that while there is several possible impairments, the extent of benefit with the Oral Tenofovir Disoproxil Fumarate, or PrEP treatment, to decrease the chance of HIV disease in people at great risk is considerable.

“Clinicians can make a real difference toward reducing the burden of HIV in the United States,” Owens said in the task force statement. “HIV screening and HIV prevention work to reduce new HIV infections and ultimately save lives.”

Fewer than half of adults have ever been tested for HIV in the U.S. and lots of those requiring more regular testing aren’t receiving it. The task force indicated that clinicians should make testing consistent and make sure patients are given an environment that’s free of opinion while analyses of sexual health.

Testing is the only means to know if someone has HIV because, after first flu-like symptoms, HIV isn’t apparent for many years.

In addition to screening, people need to stop getting HIV by applying condoms while having sex, the task force stated, and, for people who inject drugs, with clean syringes and needles.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.